HSBC Holdings’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-28,700
| Closed | -$16.6M | – | 3222 |
|
|
2025
Q4 | $16.6M | Sell |
28,700
-2,400
| -8% | -$1.36M | 0.01% | 798 |
|
|
2025
Q3 | $15.1M | Buy |
31,100
+20,000
| +180% | +$9.31M | 0.01% | 798 |
|
|
2025
Q2 | $4.5M | Sell |
11,100
-9,300
| -46% | -$3.89M | ﹤0.01% | 1192 |
|
|
2025
Q1 | $10.1M | Buy |
20,400
+3,400
| +20% | +$1.84M | 0.01% | 891 |
|
|
2024
Q4 | $8.83M | Sell |
17,000
-800
| -4% | -$440K | 0.01% | 966 |
|
|
2024
Q3 | $11M | Hold |
17,800
| – | – | 0.01% | 898 |
|
|
2024
Q2 | $9.81M | Sell |
17,800
-2,300
| -11% | -$1.32M | 0.01% | 873 |
|
|
2024
Q1 | $11.7M | Buy |
20,100
+10,000
| +99% | +$5.61M | 0.01% | 828 |
|
|
2023
Q4 | $5.36M | Buy |
+10,100
| New | +$4.89M | ﹤0.01% | 1124 |
|
|
2023
Q3 | – | Sell |
-1,600
| Closed | -$834K | – | 2853 |
|
|
2023
Q2 | $834K | Sell |
1,600
-8,500
| -84% | -$4.59M | ﹤0.01% | 1783 |
|
|
2023
Q1 | $5.76M | Buy |
10,100
+3,600
| +55% | +$2.03M | 0.01% | 1057 |
|
|
2022
Q4 | $3.56M | Buy |
6,500
+400
| +7% | +$212K | ﹤0.01% | 1429 |
|
|
2022
Q3 | $3.15M | Buy |
6,100
+4,000
| +190% | +$2.24M | 0.01% | 1365 |
|
|
2022
Q2 | $1.14M | Sell |
2,100
-1,900
| -48% | -$1.05M | ﹤0.01% | 1855 |
|
|
2022
Q1 | $2.4M | Sell |
4,000
-5,100
| -56% | -$2.93M | ﹤0.01% | 1524 |
|
|
2021
Q4 | $6.1M | Buy |
9,100
+5,100
| +128% | +$3.18M | 0.01% | 1185 |
|
|
2021
Q3 | $2.31M | Buy |
4,000
+3,100
| +344% | +$1.7M | ﹤0.01% | 1469 |
|
|
2021
Q2 | $454K | Buy |
+900
| New | +$425K | ﹤0.01% | 2252 |
|
|
2021
Q1 | – | Sell |
-7,400
| Closed | -$3.43M | – | 3127 |
|
|
2020
Q4 | $3.43M | Sell |
7,400
-2,100
| -22% | -$985K | ﹤0.01% | 1167 |
|
|
2020
Q3 | $4.21M | Buy |
9,500
+6,500
| +217% | +$2.69M | 0.01% | 1019 |
|
|
2020
Q2 | $1.09M | Sell |
3,000
-400
| -12% | -$134K | ﹤0.01% | 1406 |
|
|
2020
Q1 | $964K | Sell |
3,400
-26,200
| -89% | -$8.26M | ﹤0.01% | 1471 |
|
|
2019
Q4 | $9.59M | Buy |
29,600
+6,600
| +29% | +$2M | 0.02% | 837 |
|
|
2019
Q3 | $6.7M | Sell |
23,000
-1,600
| -7% | -$458K | 0.01% | 1044 |
|
|
2019
Q2 | $7.22M | Sell |
24,600
-9,200
| -27% | -$2.53M | 0.01% | 989 |
|
|
2019
Q1 | $9.25M | Buy |
33,800
+12,100
| +56% | +$3.01M | 0.02% | 847 |
|
|
2018
Q4 | $4.86M | Hold |
21,700
| – | – | 0.01% | 1116 |
|
|
2018
Q3 | $5.3M | Buy |
21,700
+11,200
| +107% | +$2.58M | 0.01% | 1105 |
|
|
2018
Q2 | $2.17M | Sell |
10,500
-20,700
| -66% | -$4.39M | ﹤0.01% | 1465 |
|
|
2018
Q1 | $6.44M | Buy |
+31,200
| New | +$6.55M | 0.01% | 1011 |
|
|
2017
Q4 | – | Sell |
-35,300
| Closed | -$6.68M | – | 2366 |
|
|
2017
Q3 | $6.68M | Buy |
35,300
+19,700
| +126% | +$3.57M | 0.01% | 940 |
|
|
2017
Q2 | $2.72M | Buy |
+15,600
| New | +$2.62M | 0.01% | 1175 |
|
|
2016
Q3 | – | Sell |
-50,000
| Closed | -$7.39M | – | 2117 |
|
|
2016
Q2 | $7.39M | Buy |
+50,000
| New | +$7.38M | 0.02% | 767 |
|
|
2016
Q1 | – | Sell |
-35,000
| Closed | -$4.96M | – | 2236 |
|
|
2015
Q4 | $4.96M | Buy |
+35,000
| New | +$4.67M | 0.01% | 944 |
|
Other funds holding TMO
VCM
HSBC Holdings's TMO Position: Q1 2026 in Review
HSBC Holdings reduced its Thermo Fisher Scientific (TMO) stake by 11% in Q1 2026, selling an estimated $47.7M and leaving 718,953 shares worth $353M. The position accounts for 0.18% of the portfolio, ranked #101.
HSBC Holdings first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.31B in Q4 2021. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- HSBC Holdings held 718,953 shares of Thermo Fisher Scientific worth $353M as of Q1 2026.
- HSBC Holdings sold 87,975 Thermo Fisher Scientific shares in Q1 2026, an estimated $47.7M.
- Thermo Fisher Scientific made up 0.18% of HSBC Holdings's portfolio in Q1 2026, its #101 holding.
- HSBC Holdings first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- HSBC Holdings's Thermo Fisher Scientific position peaked at $1.31B in Q4 2021.
- 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.